Market Research Report

A quick peek into the report

1.1   Product Definition
1.1.1   Inclusion and Exclusion
1.2   Market Scope
1.2.1   Scope of work
1.2.2   Key Questions Answered in Report
1.2.3   Assumptions and Limitations
1.3   Research Methodology
1.3.1   Primary Data Sources
1.3.2   Secondary Data Sources
1.3.3   Market Estimation Model
1.3.4   Criteria for Company Profiling
1.4   Global Serum-Free Media: Market Overview
1.4.1   Introduction
1.4.2   Serum-Free Media: Overview
1.4.3   Types of Cell Culture Media
1.4.3.1   Serum-Free Media vs. Serum-Based Media
1.5   COVID-19 Impact on Global Serum-Free Media Market
1.6   Global Serum-Free Media Market: Industry Analysis
1.6.1   Overview
1.6.2   Legal Requirements and Frameworks in the U.S.
1.6.3   Legal Requirements and Frameworks in Europe
1.7   Patent Landscape
1.7.1   Patent Analysis (by Country)
1.7.2   Patent Analysis (by Year)

2.1   Overview
2.2   Impact Analysis
2.2.1   Drivers
2.2.1.1   Low Risk of Contamination as a Demand Driver
2.2.1.2   Launch of innovative products in Serum-Free Media Ecosystem
2.2.1.3   Low reception cost involving small and medium enterprises in comparison to animal derived media
2.2.2   Restraints
2.2.2.1   Slow Growth Rate in Comparison to Serum-Supplemented Media
2.2.2.2   Requirement of Diverse Cell-Type for Specific Media Formulation
2.2.3   Opportunities
2.2.3.1   Regulatory Bodies Across the Globe Encourage the Use of Animal-Free Media in Biological Products
2.2.3.2   Extensive Adoption of Serum-Free Media in Biopharmaceutical Companies

3.1   Overview
3.2   Common Serum-Free
3.3   Xeno-Free
3.4   Chemically-Defined
3.5   Animal Component-Free
3.6   Protein-Free

4.1   Overview
4.2   Biopharmaceutical Companies
4.2.1   Biopharmaceutical Companies, by Media Type
4.3   Academic and Research Organizations
4.3.1   Academic and Research Organizations, by Media Type
4.4   Clinical Research Organizations
4.4.1   Clinical Research Organizations, by Media Type
4.5   Others
4.5.1   Others, by Media Type

5.1   Overview
5.2   North America
5.2.1   Overview
5.2.2   U.S.
5.2.3   Canada
5.3   Europe
5.3.1   Overview
5.3.2   Germany
5.3.3   U.K.
5.3.4   France
5.3.5   Italy
5.3.6   Spain
5.3.7   Rest-of-Europe
5.4   Asia-Pacific
5.4.1   Overview
5.4.2   China
5.4.3   Japan
5.4.4   India
5.4.5   Australia
5.4.6   South Korea
5.4.7   Rest-of-Asia-Pacific
5.5   Latin America
5.5.1   Overview
5.5.2   Brazil
5.5.3   Mexico
5.5.4   Rest-of-Latin-America
5.6   Rest-of-the-World
5.6.1   Overview
5.6.2   Middle East and Africa
5.6.3   Others

6.1   Overview
6.2   Key Developments and Strategies
6.2.1   Business Expansions
6.2.2   Product Launches and Developments
6.2.3   Mergers and Acquisitions
6.2.4   Others
6.3   Market Share Analysis (by Company)
6.4   Growth-Share Analysis (by Company)

7.1   Overview
7.2   MP BIOMEDICALS.
7.2.1   Company Overview
7.2.2   Role of MP BIOMEDICALS. in the Global Serum-Free Media Market
7.2.3   Key Competitors of the Company
7.2.4   Analyst Perspective
7.3   Corning Incorporated
7.3.1   Company Overview
7.3.2   Role of Corning Incorporated in the Global Serum-Free Media Market
7.3.3   Key Customers of the Company
7.3.4   Key Competitors of the Company
7.3.5   Financials
7.3.6   Key Insights about Financial Health of the Company
7.3.7   Analyst Perspectives
7.4   FUJIFILM Holdings Corporation
7.4.1   Company Overview
7.4.2   Role of FUJIFILM Holdings Corporation in the Global Serum-Free Media Market
7.4.3   Key Competitors of the Company
7.4.4   Financials
7.4.5   Analyst Perspective
7.5   PAN-Biotech.
7.5.1   Company Overview
7.5.2   Role of PAN-Biotech. in the Global Serum-Free Media Market
7.5.3   Key Customers of the Company
7.5.4   Key Competitors of the Company
7.5.5   Analyst Perspective
7.6   PromoCell GmbH
7.6.1   Company Overview
7.6.2   Role of PromoCell GmbH in the Global Serum-Free Media Market
7.6.3   Key Competitors of the Company
7.6.4   Analyst Perspective
7.7   HiMedia Laboratories
7.7.1   Company Overview
7.7.2   Role of HiMedia Laboratories in the Global Serum-Free Media Market
7.7.3   Key Customers of the Company
7.7.4   Key Competitors of the Company
7.7.5   Analyst Perspective
7.8   Danaher.
7.8.1   Company Overview
7.8.2   Role of Danaher. in the Global Serum-Free Media Market
7.8.3   Key Competitors of the Company
7.8.4   Financials
7.8.5   Analyst Perspective
7.9   Athena Environmental Sciences, Inc.
7.9.1   Company Overview
7.9.2   Role of Athena Environmental Sciences, Inc. in the Global Serum-Free Media Market
7.9.3   Key Competitors of the Company
7.9.4   Analyst Perspective
7.10 Lonza Group AG
7.10.1   Company Overview
7.10.2   Role of Lonza Group AG in the Global Serum-Free Media Market
7.10.3   Key Customers of the Company
7.10.4   Key Competitors of the Company
7.10.5   Financials
7.10.6   Analyst Perspective
7.11   Merck KgaA
7.11.1   Company Overview
7.11.2   Role of Merck KGaA in the Global Serum-Free Media Market
7.11.3   Key Customers of the Company
7.11.4   Key Competitors of the Company
7.11.5   Financials
7.11.6   Key Insights about Financial Health of the Company
7.11.7   Analyst Perspective
7.12   R&D Systems, Inc.
7.12.1   Company Overview
7.12.2   Role of R&D Systems, Inc. in the Global Serum-Free Media Market
7.12.3   Key Customers of the Company
7.12.4   Key Competitors of the Company
7.12.5   Analyst Perspective
7.13   Sartorius AG
7.13.1   Company Overview
7.13.2   Role of Sartorius AG in the Global Serum-Free Media Market
7.13.3   Key Customers of the Company
7.13.4   Key Competitors of the Company
7.13.5   Financials
7.13.6   Key Insights about Financial Health of the Company
7.13.7   Analyst Perspectives
7.14   Sino Biological, Inc.
7.14.1   Company Overview
7.14.2   Role of Sino Biological, Inc. in the Global Serum-Free Media Market
7.14.3   Key Customers of the Company
7.14.4   Key Competitors of the Company
7.14.5   Analyst Perspective
7.15   STEMCELL Technologies Inc.
7.15.1   Company Overview
7.15.2   Role of STEMCELL Technologies Inc. in the Global Serum-Free Media Market
7.15.3   Key Customers of the Company
7.15.4   Key Competitors of the Company
7.15.5   Analyst Perspective
7.16   Thermo Fisher Scientific Inc.
7.16.1   Company Overview
7.16.2   Role of Thermo Fisher Scientific Inc. in the Global Serum-Free Media Market
7.16.3   Key Competitors of the Company
7.16.4   Financials
7.16.5   Key Insights about Financial Health of the Company
7.16.6   Analyst Perspective

Table 1:   Likert Scale
Table 2:   Impact Analysis of Market Drivers
Table 3:   Impact Analysis of Market Restraints
Table 4:   Impact Analysis of Market Opportunities
Table 5:   Common cell lines and growth media
Table 6:   Some Companies Offering Common Serum-Free Media
Table 7:   Some Companies Offering Xeno-Free Media
Table 8:   Some Companies Offering Chemically-Defined Media
Table 9:   Some Companies Offering Animal Component-Free Media
Table 10:   Some Companies Offering Protein-Free Media

Figure 1:   Global Serum-Free Media Market, $Million, 2021-2032
Figure 2:   Global Serum-Free Media Market (by Media Type), $Million, 2021 and 2032
Figure 3:   Global Serum-Free Media Market (by End User), $Million, 2021 and 2032
Figure 4:   Global Serum-Free Media Market (by Region), $Million, 2021 and 2032
Figure 5:   Global Serum-Free Media Market Overview
Figure 6:   Global Serum-Free Media Market: Research Methodology
Figure 7:   Primary Research Methodology
Figure 8:   Bottom-Up Approach (Segment-Wise Analysis)
Figure 9:   Top-Down Approach (Segment-Wise Analysis)
Figure 10:   Food and Drug Administration’s Role
Figure 11:   Cell and Tissue Culture Supplies and Equipment
Figure 12:   European Union (EU) Guidelines for Animal-Derived Media
Figure 13:   Country-Wise Analysis of Patents, January 2020-July 2022
Figure 14:   Year-Wise Analysis of Patents, January 2020-July 2022
Figure 15:   Market Dynamics
Figure 16:   Global Serum-Free Media Market (by Media Type)
Figure 17:   Global Serum-Free Media Market (by Media Type), $Million, 2021 and 2032
Figure 18:   Global Serum-Free Media Market (Common Serum-Free), $Million, 2021-2032
Figure 19:   Global Serum-Free Media Market (Xeno-Free), $Million, 2021-2032
Figure 20:   Global Serum-Free Media Market (Chemically-Defined), $Million, 2021-2032
Figure 21:   Global Serum-Free Media Market (Animal Component-Free), $Million, 2021-2032
Figure 22:   Global Serum-Free Media Market (Protein-Free), $Million, 2021-2032
Figure 23:   Segmentation of Global Serum-Free Media Market (by End User)
Figure 24:   Global Serum-Free Media Market (by End User), $Million, 2021 and 2032
Figure 25:   Global Serum-Free Media Market (Biopharmaceutical Companies), $Million, 2021-2032
Figure 26:   Global Serum-Free Media Market (Biopharmaceutical Companies, by Media Type), $Million, 2021 and 2032
Figure 27:   Global Serum-Free Media Market (Academic Research Organization), $Million, 2021-2032
Figure 28:   Global Serum-Free Media Market (Academic Research Organizations, by Media Type), $Million, 2021 and 2032
Figure 29:   Global Serum-Free Media Market (Clinical Research Organizations), $Million, 2021-2032
Figure 30:   Global Serum-Free Media Market (Clinical Research Organizations, by Media Type), $Million, 2021 and 2032
Figure 31:   Global Serum-Free Media Market (Others), $Million, 2021-2032
Figure 32:   Global Serum-Free Media Market (Others, by Media Type), $Million, 2021 and 2032
Figure 33:   Global Serum-Free Media Market Share Overview (by Region)
Figure 34:   North America Serum-Free Media Market, $Million, 2021-2032
Figure 35:   North America: Market Dynamics
Figure 36:   North America Serum-Free Media Market (by Country), $Million, 2021 and 2032
Figure 37:   U.S. Serum-Free Media Market, $Million, 2021-2032
Figure 38:   Canada Serum-Free Media Market, $Million, 2021-2032
Figure 39:   Europe Serum-Free Media Market, $Million, 2021-2032
Figure 40:   Europe: Market Dynamics
Figure 41:   Europe Serum-Free Media Market (by Country), $Million, 2021 and 2032
Figure 42:   Germany Serum-Free Media Market, $Million, 2021-2032
Figure 43:   U.K. Serum-Free Media Market, $Million, 2021-2032
Figure 44:   France Serum-Free Media Market, $Million, 2021-2032
Figure 45:   Italy Serum-Free Media Market, $Million, 2021-2032
Figure 46:   Spain Serum-Free Media Market, $Million, 2021-2032
Figure 47:   Rest-of-Europe Serum-Free Media Market, $Million, 2021-2032
Figure 48:   Asia-Pacific Serum-Free Media Market, $Million, 2021-2032
Figure 49:   Asia-Pacific: Market Dynamics
Figure 50:   Asia-Pacific Serum-Free Media Market (by Country), $Million, 2021 and 2032
Figure 51:   China Serum-Free Media Market, $Million, 2021-2032
Figure 52:   Japan Serum-Free Media Market, $Million, 2021-2032
Figure 53:   India Serum-Free Media Market, $Million, 2021-2032
Figure 54:   Australia Serum-Free Media Market, $Million, 2021-2032
Figure 55:   South Korea Serum-Free Media Market, $Million, 2021-2032
Figure 56:   Rest-of-Asia-Pacific Serum-Free Media Market, $Million, 2021-2032
Figure 57:   Latin America Serum-Free Media Market, $Million, 2021-2032
Figure 58:   Latin America: Market Dynamics
Figure 59:   Latin America Serum-Free Media Market (by Country), $Million, 2021-2032
Figure 60:   Brazil Serum-Free Media Market, $Million, 2021-2032
Figure 61:   Mexico Serum-Free Market, $Million, 2021-2032
Figure 62:   Rest-of-Latin America Serum-Free Media Market, $Million, 2021-2032
Figure 63:   Rest-of-the-World Serum-Free Media Market, $Million, 2021-2032
Figure 64:   Rest-of-the-World Serum-Free Media Market (by Region), $Million, 2021-2032
Figure 65:   Middle East and Africa Serum-Free Media Market, $Million, 2021-2032
Figure 66:   Others Serum-Free Media Market, $Million, 2021-2032
Figure 67:   Competitive Landscape (January 2019-June 2022)
Figure 68:   Share of Key Developments and Strategies, January 2019-August 2022
Figure 69:   Business Expansions (by Company), January 2019-August 2022
Figure 70:   Product Launches and Developments (by Company), January 2019-June 2022
Figure 71:   Mergers and Acquisitions (by Company), January 2019-August 2022
Figure 72:   Others (by Company), January 2019-June 2022
Figure 73:   Market Share Analysis of Global Serum-Free Media Market (by Company), 2020 and 2021
Figure 74:   Growth-Share Analysis for Global Serum-Free Media (by Company), 2021
Figure 75:   Total Number of Companies Profiled
Figure 76:   MP BIOMEDICALS.: Product Portfolio for Global Serum-Free Media Market
Figure 77:   Corning Incorporated: Product Portfolio for Global Serum-Free Media Market
Figure 78:   Corning Incorporated: Overall Financials, $Million, 2019-2021
Figure 79:   Corning Incorporated: Revenue (by Segment), $Million, 2019-2021
Figure 80:   Corning Incorporated: Revenue (by Region), $Million, 2019-2021
Figure 81:   Corning Incorporated: R&D Expenditure, $Million, 2019-2021
Figure 82:   FUJIFILM Holdings Corporation: Product Portfolio for Global Serum-Free Media Market
Figure 83:   FUJIFILM Holdings Corporation: Overall Financials, $Million, 2019-2021
Figure 84:   FUJIFILM Holdings Corporation: Revenue (by Segment), $Million, 2019-2021
Figure 85:   PAN-Biotech.: Product Portfolio for Global Serum-Free Media Market
Figure 86:   PromoCell GmbH: Product Portfolio for Global Serum-Free Media Market
Figure 87:   HiMedia Laboratories: Product Portfolio for Global Serum-Free Media Market
Figure 88:   Danaher.: Product Portfolio for Global Serum-Free Media Market
Figure 89:   Danaher.: Overall Financials, $Million, 2019-2021
Figure 90:   Danaher.: Revenue (by Segment), $Million, 2019-2021
Figure 91:   Danaher.: Revenue (by Region), $Million, 2019-2021
Figure 92:   Danaher.: R&D Expenditure, $Million, 2019-2021
Figure 93:   Athena Environmental Sciences, Inc.: Product Portfolio for Global Serum-Free Media Market
Figure 94:   Lonza Group AG: Product Portfolio for Global Serum-Free Media Market
Figure 95:   Lonza Group AG: Overall Financials, $Million, 2019-2021
Figure 96:   Lonza Group AG: Revenue (by Segment), $Million, 2019-2021
Figure 97:   Merck KGaA: Product Portfolio for Global Serum-Free Media Market
Figure 98:   Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 99:   Merck KGaA: Revenue (by Segment), $Million, 2019-2021
Figure 100:   Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 101:   Merck KGaA: R&D Expenditure, $Million, 2019-2021
Figure 102:   R&D Systems, Inc.: Product Portfolio for Global Serum-Free Media Market
Figure 103:   Sartorius AG: Product Portfolio for Global Serum-Free Media Market
Figure 104:   Sartorius AG: Overall Financials, $Million, 2019-2021
Figure 105:   Sartorius AG: Revenue (by Segment), $Million, 2019-2021
Figure 106:   Sartorius AG: Revenue (by Region), $Million, 2019-2021
Figure 107:   Sartorius AG: R&D Expenditure, $Million, 2019-2021
Figure 108:   Sino Biological, Inc.: Product Portfolio for Global Serum-Free Media Market
Figure 109:   STEMCELL Technologies Inc.: Product Portfolio for Global Serum-Free Media Market
Figure 110:   Thermo Fisher Scientific Inc.: Product Portfolio for Global Serum-Free Media Market
Figure 111:   Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 112:   Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 113:   Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021
Figure 114:   Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021

Market Report Coverage

Global Serum-Free Media Market
Base Year	2021	Market Size in 2021	$1,022.4 Million
Forecast Period	2022-2032	Value Projection and Estimation by 2032	$3,920.5 Million
CAGR During Forecast Period	12.73%	Number of Tables	10
Number of Pages	165	Number of Figures	114

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

Company Type 1: Serum-Free Media Private Industry
•   MP BIOMEDICALS.
•   HiMedia Laboratories
•   R&D Systems, Inc.
•   Sino Biological, Inc.
•   PAN-Biotech.
•   PromoCell GmbH
•   Athena Environmental Sciences, Inc.
•   STEMCELL Technologies Inc.

Company Type 2: Serum-Free Media Public Industry
•   Corning Incorporated
•   Lonza Group AG
•   Merck KgaA
•   Sartorius AG
•   Thermo Fisher Scientific Inc.
•   FUJIFILM Holdings Corporation
•   Danaher.

How can this report add value to an organization?

Product/Innovation Strategy: The report considers serum-free media products from product-based companies. These companies are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting.

Growth/Marketing Strategy: Owing to the explosion of massively parallel cell therapy and gene editing, all areas of healthcare have been affected, particularly serum-free media-based cellular diagnostics. The key components in the serum-free media market consist of a diverse range of media types as products. The entire workflow is well explained in the report, along with pricing analysis considering the applications that are used in testing.

Competitive Strategy: Key players in the global serum-free media market were analyzed and profiled in the study, consisting of both products-based companies as well as a few emerging companies. Moreover, a detailed competitive benchmarking of the players operating in the global serum-free media market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Industry and Technology Overview

Global Serum-Free Media Market Industry Overview

The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032. The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development.

Market Lifecycle Stage

The global serum-free media market is progressing rapidly with a significant increase in research and development activities pertaining to a wide range of animal component-free products for disease detection, accentuating their criticality in healthcare. Serum-free media has a critical role in the cellular diagnostics approach, as it ensures the safe and effective application for improved cell culture and cell therapy-based methods.

Increasing investments in R&D for cell-based diagnostics is one of the major opportunities in the serum-free media market. Several clinical organizations and biopharmaceutical companies are working collaboratively on molecular biology applications, cell biology, cancer research, metagenomics, and plant research using serum-free media as a therapeutic means for applications in several disease indications in order to enable efficient diagnosis, treatment selection, dosage selection, and treatment monitoring.

Figure: Global Serum-Free Media Market Snapshot

Source: BIS Research Analysis

Impact

Several techniques are employed in the development of serum-free media utilization for the process of removing cells, tissues, or organs from an animal or plant and putting them into a setting that will help them survive and/or proliferate. The selection of an adequate growth medium for in vitro cultivation is the most significant and important phase in cell culture. A growth medium, also known as a culture media, is a solution, gel, or powder that promotes the development of cells, small plants, or microorganisms. This serum-free medium market space has been segmented into different media types that include common serum-free, xeno-free, chemically-defined, animal component-free, and protein-free. Some of these media types are described in brief as follows:

•   Common serum-free media: In common serum-free media, the composition is precisely defined, ensuring lot-to-lot consistency and eliminating the need to screen new lots of serum. In addition to facilitating the growth of numerous cell types for study, serum-free media also provide the advantage of removing the threat of infectious pathogens. The common serum-free media does not include human or animal serum or plasma in its direct or basic constituents.
•   Chemically-defined media: Chemically-defined media is beneficial for a range of physiological research as well as for examining the minimal needs of microorganisms. Chemically-defined media are known to increase productivity and reduce costs in cell culture applications. A specified medium will enhance reproducibility and enable a more precise prediction of the final yield from a certain procedure.
•   Animal component-free media: Animal-free media, also known as animal component-free and animal origin-free cell culture media, can offer the essential components required for cell growth and performance similar to the media, including serum, but without the drawbacks associated with using the serum. Animal component-free media not only mitigates the risk of prions and other viral contaminants but also improves regulatory approvals and speed-to-market.
•   Protein-free media: The protein-free media are ideal for producing proteins as they promote healthy cell development and excellent protein yield. The proteins in the protein-free medium can be substituted with low-molecular-weight components such as peptides, hormones, and inorganic ions. However, protein-free designated commercially available media frequently contain just trace amounts of recombinant proteins.

Impact of COVID-19

The current global serum-free media market comprises different media types. The unexpected crisis of the pandemic has surged the demand for essentials and thus, increased the demand for serum-free media. There was increased demand for serum-free media from biopharmaceutical companies. Overall, the impact of COVID-19 on the global serum-free media market size has been low-moderate. Some of the market players have reported a slight decline in sales. However, it is worth mentioning that with the ease of restrictions after Q2 2021, the market for serum-free media gained significant momentum and is anticipated to grow during the forecast period 2022-2032. As a result of the pandemic and reduced output at manufacturing facilities, the pandemic caused a short-term drop in manufacturing and sales of serum-free media. The global serum-free media market will eventually return to its usual growth trajectory over time. With many people impacted by COVID-19 all around the world, pharmaceutical companies are ramping up manufacturing to create vaccinations. Such trends are generating revenue potential for serum-free media market participants. Lonza Group AG, a Swiss multinational chemicals and biotechnology firm, is earning notoriety for its non-animal ProVeroTM1 Serum-free Medium, which aids in vaccine manufacture.

Market Segmentation:

Segmentation 1: by Media Type
•   Common Serum-Free
•   Xeno-Free
•   Chemically-Defined
•   Animal Component-Free
•   Protein-Free

The global serum-free media market in the media type segment is expected to be dominated by common serum-free media. This is due to an increased usage of common serum-free media, and it is the most used media type among manufacturers offering cell culture media to their end users.

Segmentation 2: by End User
•   Biopharmaceutical Companies
•   Academic and Research Organizations
•   Clinical Research Organizations
•   Others

The biopharmaceutical companies dominate the end user segment in the global serum-free media market as increasing global serum-free media research activities are expected to contribute to the growth of the market along with growing industry-academic collaborations for new product development.

Segmentation 3: by Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Rest-of-the-World

The global serum-free media market is dominated by North America. This is majorly due to the presence of a large number of biopharmaceutical companies in the area, along with the research funding for cell and stem cell-based products. However, with advancements in technology and the growing demand for serum-free media in Asia-Pacific, the region is expected to be the fastest growing region.

Recent Developments in the Global Serum-Free Media Market

•   In August 2022, Thermo Fisher Scientific Inc. expanded the cell culture media manufacturing facility in Grand Island, New York, to support the production of new vaccines and biologics. This expansion would support the worldwide media supply and increase the capacity to create high-quality technologies.
•   In May 2022, FUJIFILM Irvine Scientific completed its new bioprocessing innovation and collaboration center in China. The new center would enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
•   In September 2021, Bio-Techne Corporation developed a new medium ExCellerate IpsC expansion medium, for IpsC research in regenerative medicine.
•   In April 2021, PromoCell GmbH launched an upgrade to its Keratinocyte Cell Culture Portfolio. The company expanded its improved animal-extract-free Keratinocyte Growth Medium 3 for the standardized isolation and development of juvenile and adult Normal Human Keratinocytes.
•   In March 2021, the company also launched its improved third-generation Melanocyte Cell Culture Portfolio. Melanocyte Growth Medium M3 is a serum-free, bovine pituitary extract (BPE)-free, and phorbol myristate acetate (PMA)-free media formulation.

Demand – Drivers and Limitations

Following are the demand drivers for the global serum-free media market:

•   Low Risk of Contamination as a Demand Driver
•   Launch of innovative products in Serum-Free Media Ecosystem
•   Low reception cost involving small and medium enterprises in comparison to animal derived media

The market is expected to face some limitations too due to the following challenges:

• Slow Growth Rate in Comparison to Serum-Supplemented Media
• Requirement of Diverse Cell-Type for Specific Media Formulation

Analyst Thoughts

According to Nitish Kumar, Principal Analyst, BIS Research, “Global serum-free media market has evolved to be an integrative aspect of healthcare procedures by providing most diagnostic laboratory tests equipped with infectious disease, oncology, and genetics. The massively parallel methods that have now transcended media-based cellular diagnostics further allow the sequencing of entire genomes at very low costs and are expected to grow further in the coming years due to the continuous increase in prognostic assessments for a wide range of diseases."